Sr Director, CDTL

Compound Development Team Leader (CDTL) - Autoantibody, Immunology

Janssen Research and Development, L.L.C., a member of Johnson and Johnson's Family of Companies, is recruiting for a Compound Development Team Leader (CDTL), to be located in San Diego, CA; Boston, MA; or Spring House, PA.

Remote work options may be considered on a case-by-case basis and if approved by the Company.

At the Johnson & Johnson, what matters most is helping people live full and healthy lives.

We focus on treating, curing and preventing some of the most devastating and complex diseases of our time.

And we pursue the most promising science, wherever it might be found.

As Immunology Leaders, we know immunology is vital to human health.

Driven by a relentless focus on patient unmet needs, we will redefine treatments for immune diseases by delivering transformational and accessible therapies and regimens to patients with immune-mediated disease.

For more than two decades we have been a world leader in the development of transformational medicines, establishing one of the strongest, first-in-class portfolios and pipelines in the industry, including the first tumor necrosis factor (TNF) inhibitor, and first interleukin (IL)-12 and IL-23 inhibitors.

We tirelessly push the boundaries of science and creativity, applying our deep disease insights, novel pathway science, new technologies, and treatment modalities to restore immune homeostasis.

Janssen Research & Development, LLC.

discovers and develops innovative medical solutions to address important unmet medical needs in the following therapeutic areas: immunology, oncology, neuroscience, infectious diseases & vaccines, cardiovascular & metabolism, and pulmonary hypertension.

Please visit http://www.JanssenRnD.com for more information.

We are J&J.

Our mission drives us.

Our patients inspire us.

We collaborate with the world for the health of everyone in it.

We are guided by our Credo.

Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion.

Proud to be an equal opportunity employer.

The early Compound Development Team Leader (CDTL) will work within the Autoantibody team focused on the early portfolio and molecular differentiation.

The CDTL will partner closely with the Portfolio & Asset Management organization as part of the wider CDTL community.

They will lead a cross-functional compound development team to maximize the value of the asset and drives execution of the compound strategy.

The CDTL champions the project(s) at all levels of J&J through providing clear communication, creative strategic approaches to development and securing appropriate resources to deliver on the milestones.

They will also integrate the molecular differentiation work across the portfolio.

The eCDTL leads a cross-functional matrix compound development team to deliver against the asset strategy.

Beginning at Lead Optimization entry the eCDTL drives the development and execution of the com...